Top 5 Up And Coming Companies For 2014

Introduction

In this article I'll follow up on my earlier article on Telefonica (TEF) 'Why Telefonica might be a good investment right now', and have a look at the company's H1 financial results which were published last week. I'll first discuss the numbers, have a closer look at the debt level (as it's one of Telefonica's priorities to considerably reduce this debt) and give my updated opinion at the end of this article.

I recalculated all numbers from Euro to USD using an EUR/USD exchange rate of 1.33.

The H1 Financial results

Looking at the consolidated income statement, revenue came in at 28.5B EUR (37.9B USD) which is down 7.8% from 2012's 31B EUR (41.2B USD). The OIBDA margin (Operating Income Before Depreciation and Amortization) remained relatively stable at 33%, down from 33.7%.

The net income came in at 2.06B EUR (2.75B USD), down just 0.9% from 2.08B (2.77B USD) in the same period last year. This stable net income was mainly caused by lower financial expenses (1.4B EUR (1.86B USD) versus 1.59B EUR (2.11B USD) last year) and lower income taxes (751M EUR (999M USD) vs 960M EUR (1.28B USD)). These two accounts had a positive impact of approximately 400M EUR (532M USD) on the net income and that's the main reason why net income was down by less than a percent despite the 7.8% drop in revenue and 9.7% drop in OIBDA.

Hot Paper Companies To Watch In Right Now: Peoples Bancorp Inc.(PEBO)

Peoples Bancorp Inc. operates as a holding company for Peoples Bank, National Association that provides financial products and services. It offers commercial and retail banking, insurance, brokerage, and trust services. The company accepts various deposit products, including demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; and provides commercial, consumer, and real estate mortgage loans, as well as lines of credit. It also offers debit and automated teller machine (ATM) cards; corporate and personal trust services; safe deposit rental facilities; travelers checks, money orders, and cashier?s checks; and telephone and Internet-based banking services. In addition, the company provides a range of life, health, and property and casualty insurance products; and fiduciary and wealth management services. Further, it offers brokerage services through an unaffiliated registered broker-dealer; and credit cards to consumers and business es, as well as provides merchant credit card processing services through joint marketing arrangements with third parties. The company offers its financial products and services through 47 financial service locations and 40 ATMs in southeastern Ohio, northwestern West Virginia, and northeastern Kentucky. Peoples Bancorp Inc. was founded in 1902 and is based in Marietta, Ohio.

Advisors' Opinion:

• [By Marc Bastow]

  Marietta, Ohio-based bank holding company Peoples Bancorp (PEBO) raised its quarterly dividend 7% to 15 cents per share, payable on Feb. 18 to shareholders of record as of Feb. 3.
  PEBO Dividend Yield: 2.60%

Top 5 Up And Coming Companies For 2014: Alleghany Corporation(Y)

Alleghany Corporation, through its subsidiaries, engages in the property and casualty, and surety insurance business in the United States. It underwrites specialty insurance coverages in the property, umbrella/excess, general liability, directors and officers liability, professional liability lines of business, and homeowners insurance. The company also writes surety products, such as commercial surety bonds and contract surety bonds. In addition, Alleghany Corporation owns and manages improved and unimproved commercial land, and residential lots in the Sacramento, California. As of December 31, 2010, the company owned approximately 320 acres of property in various land use categories. Further, it engages in the oil and gas exploration and production business. The company was founded in 1929 and is based in New York, New York.

Advisors' Opinion:

• [By Chris Hill]

  Which investors are worth following? In this installment of MarketFoolery, our analysts talk about why they're following Cook and Bynum's Richard Cook and Dowe Bynum, Martin Capital's Frank Martin, Alleghany's (NYSE: Y  ) CEO Weston Hicks, and T. Rowe Price's (NASDAQ: TROW  ) �Preston Athey.�

Top 5 Up And Coming Companies For 2014: ReachLocal Inc.(RLOC)

ReachLocal, Inc. provides a suite of online marketing and reporting solutions to small and medium-sized businesses (SMBs) primarily in the United States, Canada, Australia, the United Kingdom, India, the Netherlands, Germany, and Japan. The company?s products include ReachSearch, a search engine marketing product; ReachDisplay, a display advertising and remarketing product; ReachCast, a solution that builds and optimizes Web presence for the purpose of driving online search discovery, powering reputation management, and managing social media marketing; and remarketing and retargeting products. It also provides a suite of digital marketing solutions comprising TotalTrack, TotalLiveChat, TotalVideoNow, and TotalBannerNow to address specific marketing needs, such as lead optimization, online analytics, and digital creative solutions. The company serves clients in various industry verticals, such as home repair and improvement, automobile sales and repair, medical and health services, legal services, and retail and personal services. It delivers its solutions through a combination of its proprietary ReachLocal Platform and direct sales force of Internet marketing consultants, as well as through select third-party agencies and resellers. ReachLocal, Inc. was founded in 2003 and is headquartered in Woodland Hills, California.

Advisors' Opinion:

• [By Jeremy Bowman]

  What: Shares of ReachLocal (NASDAQ: RLOC  ) were moving the wrong way today, falling as much as 19% after providing disappointing guidance in its quarterly report.

Top 5 Up And Coming Companies For 2014: BIND Therapeutics Inc (BIND)

BIND Therapeutics, Inc., incorporated on May 19, 2006, is a clinical-stage nanomedicine platform company developing Accurins, its targeted and programmable therapeutics. Accurins are designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease to enhance efficacy while minimizing adverse effects on healthy tissues. Its drug candidate, BIND-014, is in Phase II clinical trials for non-small cell lung cancer, or NSCLC, and metastatic castrate-resistant prostate cancer (mCRPC).

Accurins represent the evolution of targeted therapies and nanomedicine. Accurins are polymeric nanoparticles that incorporate a therapeutic payload and are designed to have prolonged circulation within the bloodstream, enable targeting of the diseased tissue or cells, and provide for the controlled and timely release of the therapeutic payload. The four components include Targeting ligands, Stealth and protective layer, Controlled-release polymer matrix and Therapeutic payload. The Company focuses to use its medicinal nanoengineering platform to develop Accurins in several therapeutic areas, with an initial focus on the treatment of various types of cancer. In addition, the Company entered into collaboration agreements with several biopharmaceutical companies to develop and commercialize Accurins that are based on its collaborators��therapeutic payloads. The Company�� programs include BIND-014, solid tumor accurin and hematologic cancer accurin.

Advisors' Opinion:

• [By Anna Prior]

  Bind Therapeutics sa(BIND)id a collaboration with Amgen Inc.(AMGN) has been ended after both companies agreed not to pursue an option to jointly develop a molecularly targeted cancer therapy. Bind Therapeutics shares fell 11% to $11.50 premarket.

• [By John Udovich]

  If you have not been watching the biotech sector lately, you should start paying attention as the sector along with small cap biotech stocks like Cell Therapeutics Inc (NASDAQ: CTIC), BIND Therapeutics Inc (NASDAQ: BIND) and TNI BioTech (OTCMKTS: TNIB) continue to produce a steady stream of good news for investors thanks to positive industry trends. Moreover, Ophthotech Corp (NASDAQ: OPHT), Foundation Medicine Inc (NASDAQ: FMI), Evoke Pharma and Fate Therapeutics Inc (NASDAQ: FATE) are this week's biotech IPOs that will no doubt be watched closely by Wall Street and industry observers in general. With that in mind, consider the following biotech news or recent articles about the industry and the small cap players in it:

• [By Garrett Cook]

  BIND Therapeutics (NASDAQ: BIND) was down, falling 10.56 percent to $11.52 after the company reported the closing of collaboration deal with Amgen (NASDAQ: AMGN).

• [By John Udovich]

  The biotech sector has been pretty exciting this year�with small cap biotech stocks Prana Biotechnology Limited (NASDAQ: PRAN) and TNI BioTech (OTCMKTS: TNIB) having recently produced noteworthy news for investors�while Acceleron Pharma, Inc (NASDAQ: XLRN), Ophthotech (NASDAQ: OPHT) and BIND Therapeutics (NASDAQ: BIND) have just�set term sheets for their upcoming IPOs. Just consider all of the following recent news: